ÂÜÀòÂÒÂ×

Angeliki Chalkiadaki, PhD, is a Principal Scientist and Program Lead at ARase Therapeutics since September 2021 and serves as an Expert Evaluator for the European Commission since 2017. Previously, Angeliki held roles such as Group Lead in Metabolism and Senior Scientist at Cellarity from February 2019 to September 2021, and Senior Research Scientist at the Wyss Institute for Biologically Inspired Engineering from September 2016 to January 2019. Angeliki's early career includes positions as a Research Scientist and Postdoctoral Researcher at the Massachusetts Institute of Technology from November 2005 to September 2016, as well as a brief tenure as a Scientific Editor at Nature Publishing Group in 2012. Educational qualifications include a PhD in Molecular Biology and Biomedicine, a Master's degree in Molecular Biology and Biomedicine, and a Bachelor's degree in Biology, all from the University of Crete.